Arcadia Biosciences
RKDA
18 hedge funds and large institutions have $3.1M invested in Arcadia Biosciences in 2019 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 5 closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 1
111% more capital invested
Capital invested by funds: $1.47M → $3.1M (+$1.63M)
80% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 5
29% more funds holding
Funds holding: 14 → 18 (+4)
0% more ownership
Funds ownership: 0.19% → 0.19% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
D.E. Shaw & Co
New York
|
+$952K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$552K |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
+$144K |
| 4 |
BAM
Blueshift Asset Management
Red Bank,
New Jersey
|
+$141K |
| 5 |
Squarepoint
New York
|
+$127K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$414K |
| 2 |
Morgan Stanley
New York
|
-$380K |
| 3 |
VF
Virtu Financial
New York
|
-$61K |
| 4 |
Renaissance Technologies
New York
|
-$48K |
| 5 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
-$34K |
RKDA Hedge Fund Activity: Q3 2019 in Review
18 of the 4,574 institutional investors tracked by Wall St. Rank reported a position in Arcadia Biosciences (RKDA) for Q3 2019, worth a combined $3.1M — up 111% from $1.47M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new RKDA positions and 5 closed out — a net gain of 4 holders — while 4 added to existing stakes and 1 trimmed.
The largest buyer was D.E. Shaw & Co, opening a new position worth an estimated $952K. The largest seller was CVI Holdings, exiting entirely with an estimated $414K sold.
- 18 institutional investors held Arcadia Biosciences (RKDA) as of Q3 2019, up from 14 in Q2 2019.
- Funds reported $3.1M of Arcadia Biosciences stock for Q3 2019, up 111% quarter-over-quarter.
- 9 funds opened new Arcadia Biosciences positions in Q3 2019 and 5 closed out, a net change of +4 holders.
- The largest Arcadia Biosciences buyer in Q3 2019 was D.E. Shaw & Co, an estimated $952K added.
- The largest Arcadia Biosciences seller in Q3 2019 was CVI Holdings, an estimated $414K sold.
Based on aggregated 13F filings for Q3 2019.